Sarah Davis, MD
Obstetrics & Gynecology · Birmingham, ALNPI 1710922968
Payments from drug & device makers
Across 88 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$406
- Astellas Pharma US Inc$244
- Coopersurgical, Inc.$147
- Amgen$107
- Hologic Sales And Service, LLC$84
- Millicent US Inc$58
- plus $492 from 18 others
What the payments were for
- Food & beverage$1,41892%
- Education$1208%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $406 |
| Astellas Pharma US Inc | 11 | $244 |
| Coopersurgical, Inc. | 4 | $147 |
| Amgen | 7 | $107 |
| Hologic Sales And Service, LLC | 6 | $84 |
| Millicent US Inc | 4 | $58 |
| Johnson & Johnson | 2 | $51 |
| Duchesnay USA Incorporated | 4 | $47 |
| Pfizer | 3 | $47 |
| Shield Therapeutics Inc | 3 | $46 |
| AMAG Pharmaceuticals, Inc. | 2 | $35 |
| Mayne Pharma Commercial LLC | 3 | $34 |
| Boston Scientific | 2 | $29 |
| Sumitomo Pharma America, Inc. | 2 | $28 |
| Tempus AI, Inc | 1 | $26 |
| Sage Therapeutics, LLC | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Organon | 1 | $18 |
| Siemens Medical Solutions USA, Inc. | 1 | $18 |
| Medtronic | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $14 |
| BD | 1 | $13 |
| Nalpropion Pharmaceuticals LLC | 1 | $12 |
How this compares
$1,538 in reported general payments places this provider in the 50th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 64 | $4,019 |
| YuvafemEstradiol | 12 | $2,513 |
| Risedronate Sodium | 15 | $2,485 |
| DottiEstradiol | 14 | $2,275 |
| Estradiol (Twice Weekly)Estradiol | 11 | $633 |
| ValacyclovirValacyclovir Hcl | 14 | $622 |
| Clonazepam | 16 | $44 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Birmingham
- Charles SharpBirmingham$2.8M
- Ronald OrsoBirmingham$1.6M
- Theodore TsaltasBirmingham$853K
- Janeen ArbuckleBirmingham$601K
- Tomeka RobertsBirmingham$44K
- Percy HudsonBirmingham$29K
- Heidi StraughnBirmingham$29K
- William HudsonBirmingham$13K
- William JohnsonBirmingham$10K
- Cynthia BrownBirmingham$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.